Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511]

Liu, Xinxue; Munro, Alasdair P.S.; Feng, Shuo; Janani, Leila; Aley, Parvinder K.; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dejnirattisai, Wanwisa; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L.; Green, Christopher A.; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A.; Kwok, Jonathan; Libri, Vincenzo; Llewelyn, Martin J.; McGregor, Alastair C.; Minassian, Angela M.; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F.; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R.; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Serafimova, Teona; Saralaya, Dinesh; Screaton, Gavin R.; Sharma, Sunil; Sheridan, Ray; Sturdy, Ann; Supasa, Piyada; Thomson, Emma C.; Todd, Shirley; Twelves, Chris; Read, Robert C.; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S.; Cornelius, Victoria; Snape, Matthew D.; Faust,...

Abstract

The authors regret that there has been an error published within Fig. 5 of this article. The authors inadvertently pasted the anti-spike plots for the “≥70 years” group instead of the pseudo-neutralising antibody plots (pages 808–809) to Fig. 5A and B. These plots replicate the “≥70 years” group in Fig. 4A and B on pages 806–807. The authors have confirmed that the error does not affect the interpretation of the results and the rest of the paper, and the plots for the “<70 years” group in Fig. 5 are correct. The revised Fig. 5 contains the correct plots for pseudo-neutralising antibody data has now been updated in the original publication. The authors would like to apologise for any inconvenience caused.

Citation

Liu, X., Munro, A. P., Feng, S., Janani, L., Aley, P. K., Babbage, G., Baxter, D., Bula, M., Cathie, K., Chatterjee, K., Dejnirattisai, W., Dodd, K., Enever, Y., Qureshi, E., Goodman, A. L., Green, C. A., Harndahl, L., Haughney, J., Hicks, A., van der Klaauw, A. A., …study group, C.-B. (2023). Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511]. Journal of Infection, https://doi.org/10.1016/j.jinf.2023.03.025

• Journal Article Type: Addendum
• Acceptance Date: Apr 11, 2023
• Online Publication Date: Apr 12, 2023
• Publication Date: Apr 12, 2023
• Deposit Date: Apr 19, 2023
• Publicly Available Date: Apr 19, 2023
• Journal: Journal of Infection
• Print ISSN: 0163-4453
• Electronic ISSN: 1532-2742
• Publisher: Elsevier
• Peer Reviewed: Peer Reviewed
• DOI: https://doi.org/10.1016/j.jinf.2023.03.025
• Public URL: https://nottingham-repository.worktribe.com/output/19782803
• Publisher URL: https://www.journalofinfection.com/article/S0163-4453(23)00198-6/fulltext
• Related Public URLs: https://www.sciencedirect.com/science/article/pii/S0163445322002006?via%3Dihub
• Additional Information: This article is maintained by: Elsevier; Article Title: Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial” [J Infect 84(6) (2022) 795–813, 5511]; Journal Title: Journal of Infection; CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jinf.2023.03.025; CrossRef DOI link to the associated document: https://doi.org/10.1016/j.jinf.2022.04.018; Content Type: simple-article; Copyright: © 2023 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.